Program

5.00 - 5.15pm AEST   Registration

5.15 - 5.30pm AEST   Welcome and introduction
Welcome: Prof Jason Roberts, The University of Queensland, CRE REDUCE, Brisbane, Australia
Chair: Dr Suzanne Parker, The University of Queensland, Brisbane Australia
 

 

 

 

5.30 - 6.00pm AEST   Bedside measurement of antimicrobials for therapeutic drug monitoring
Dr Daniel Owens, University of Southampton, United Kingdom
Dr Dave Rowe, University of Southampton, United Kingdom
 

 

 

 

6.00 - 6.30pm AEST   The application of microsampling to forensic toxicology
Professor Christophe Stove, Ghent University, Belgium
 

 

 

 

6.30 - 7.00pm AEST   Microsampling to facilitate pharmacokinetics studies in remote and rural settings
Professor Jan-Willem Alffenaar, The University of Sydney, Sydney, Australia
 

 

 

 

7.00 - 7.30pm AEST   Paediatric pharmacokinetics facilitated by microsampling: the PIMS study
Dr Tavey Dorofaeff, Paediatric Intensive Care, Children's Health Queensland, Brisbane, Australia
 

 

 

 

7.30 - 8.00pm AEST   Neonatal Therapeutic Drug Monitoring (TDM) using microsampling 
Dr Adam Irwin, UQ Centre for Clinical Research, Brisbane, Australia
Dr Suzanne Parker, UQ Centre for Clinical Research, Brisbane, Australia
 

 

 

 

8.00 - 8.30pm AEST   Vancomycin Microsampling Assay: Application to the analysis of capillary and venous/arterial whole blood samples from children
Dr Ganesh Moorthy, The Children's Hospital of Philadelphia, USA
 

 

 

 

Invitation to form a Collaborative Microsampling Network | Questions & Answers

 

 

 

About Application of Microsampling for Improved Clinical Care in Infectious Diseases

Repeated blood sampling of paediatric patients using conventional methods results in relatively large amounts of blood drawn, which is inconvenient and not optimal given the limited availability of blood. Microsampling techniques facilitate collection of samples from a finger or heel prick, which involves much smaller volumes of blood. However, the applicability of micro over conventional sampling and antibiotic dosing requires further validation. 

This workshop aims to expand practitioners’ understanding of the benefits and limitations of the application of microsampling to therapeutic drug monitoring. Participants will also learn about the application of microsampling in toxicokinetic and pharmacokinetic studies and the qualitative and quantitative challenges associated with this technique.

Delivered in the evening Australian Eastern Standard Time, this workshop will aim to reach audiences in Philadelphia, USA, Europe and the Asia-Pacific time zones.

Learning objectives

  1. Understanding the application of microsampling to therapeutic drug monitoring
  2. Understanding the application of microsampling to toxicokinetics / pharmacokinetic studies
  3. Challenges associated with microsampling, qualitative and quantitative

Join Dr Suzanne Parker and colleagues for this insightful workshop.